Radius Ventures

Radius Ventures is a healthcare-specialist investment firm with a long history of backing healthcare and life-sciences growth companies, with particular emphasis on healthier-living and wellness-adjacent businesses, healthcare services, consumer health, medical devices and selective digital health. The firm typically invests at growth stage rather than seed, with check sizes plausibly in the $5M to $20M range as a participant in or co-lead of Series B and later rounds, often with structured terms and meaningful ownership preferences. Geographic focus is US-centric. For healthcare founders, Radius is most relevant if you are at or approaching growth stage with proven commercial traction in healthcare services, consumer health, wellness, medical devices or commercial-stage digital health, where a sector-specialist growth investor adds capital, sector network and IPO-pathway credibility. The firm is a poor fit for very early-stage seed companies, pre-revenue therapeutics where biotech specialists are better aligned, and pure technology platforms without a healthcare commercial application. Founders should expect rigorous commercial and operational diligence, demanding board engagement and well-formed views on healthcare-specific commercial strategy. Entry is best via warm introductions from existing portfolio CEOs, healthcare-focused investment bankers or fellow healthcare VCs in earlier rounds; cold outbound is significantly less effective at growth-stage profiles like this. Founders should clarify current fund stage, position size preferences, board posture, follow-on philosophy, and IPO trajectory expectations early in any conversation, given the firm’s specialist orientation toward later-stage commercial healthcare businesses.